Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK.
ESC Heart Fail. 2023 Apr;10(2):1222-1230. doi: 10.1002/ehf2.14283. Epub 2023 Jan 25.
This study aimed to examine the association between cardiovascular health (CVH) metrics and the risk of heart failure (HF) in a Finnish population.
We used the prospective population-based Kuopio Ischaemic Heart Disease cohort study comprising men aged 42-60 years at baseline (1984-89) and women aged 53-73 years at baseline (1998-2001). The CVH scores were computed from American Heart Association's CVH metrics for 2385 men and 825 women without a history of HF at baseline. The CVH scores, ranging from 0 to 14, were categorized into three: inadequate, average, and optimal groups. Multivariable Cox regression models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for HF. During a median follow-up period of 27 years for men, and 18 years for women, 465 and 124 HF events were recorded, respectively. The mean ages for men and women were 53 and 63 years, respectively. One hundred and thirty-three men (5.6%) and 73 women (8.8%) had five or more ideal CVH metrics. Participants with optimal CVH scores had a 64% and 48% lower risk of HF when compared with those with inadequate CVH scores among men and women, respectively (HR, 95% CI: men = 0.36, 0.26-0.49, P < 0.01; women = 0.52, 0.31-0.89, P = 0.02).
Optimal CVH metrics is associated with a lower risk of HF among an ageing Finnish population. Optimal CVH score should be targeted among the general population to reduce the risk of HF.
本研究旨在探讨芬兰人群中心血管健康(CVH)指标与心力衰竭(HF)风险之间的关联。
我们使用前瞻性基于人群的库奥皮奥缺血性心脏病队列研究,该研究纳入了基线时(1984-89 年)年龄在 42-60 岁的男性和基线时(1998-2001 年)年龄在 53-73 岁的女性。根据美国心脏协会的 CVH 指标计算 2385 名男性和 825 名基线时无 HF 病史的女性的 CVH 评分。CVH 评分范围为 0 至 14,分为三组:不足、平均和最佳。多变量 Cox 回归模型用于估计 HF 的风险比(HR)和 95%置信区间(CI)。在男性的中位随访期为 27 年,女性的中位随访期为 18 年期间,分别记录了 465 例和 124 例 HF 事件。男性和女性的平均年龄分别为 53 岁和 63 岁。133 名男性(5.6%)和 73 名女性(8.8%)有 5 个或更多理想的 CVH 指标。与 CVH 评分不足的男性和女性相比,CVH 评分最佳的参与者发生 HF 的风险分别降低了 64%和 48%(HR,95%CI:男性=0.36,0.26-0.49,P<0.01;女性=0.52,0.31-0.89,P=0.02)。
在芬兰老年人群中,最佳 CVH 指标与 HF 风险降低相关。应针对普通人群设定最佳 CVH 评分,以降低 HF 风险。